User profiles for RUI MANUEL REIS
Rui Manuel ReisBarretos Cancer Hospital (Brazil) and Minho University (Portugal) Verified email at hcancerbarretos.com.br Cited by 42778 |
[HTML][HTML] Frequency of TERT promoter mutations in human cancers
Reactivation of telomerase has been implicated in human tumorigenesis, but the underlying
mechanisms remain poorly understood. Here we report the presence of recurrent somatic …
mechanisms remain poorly understood. Here we report the presence of recurrent somatic …
Planning cancer control in Latin America and the Caribbean
Non-communicable diseases, including cancer, are overtaking infectious disease as the
leading health-care threat in middle-income and low-income countries. Latin American and …
leading health-care threat in middle-income and low-income countries. Latin American and …
[HTML][HTML] Cervical cancer in low and middle‑income countries
…, C Hicks, SM Wang, RM Reis… - Oncology …, 2020 - spandidos-publications.com
Cervical cancer is a malignant tumour that occurs in the cervix and is classified into two
histological types, adenocarcinoma and squamous cell carcinoma (SCC); SCC is more common …
histological types, adenocarcinoma and squamous cell carcinoma (SCC); SCC is more common …
[HTML][HTML] Role of glioblastoma stem cells in cancer therapeutic resistance: A perspective on antineoplastic agents from natural sources and chemical derivatives
Glioblastoma (GBM) is the highest-grade form of glioma, as well as one of the most aggressive
types of cancer, exhibiting rapid cellular growth and highly invasive behavior. Despite …
types of cancer, exhibiting rapid cellular growth and highly invasive behavior. Despite …
[HTML][HTML] Serrated pathway in colorectal carcinogenesis
…, C Scapulatempo-Neto, RM Reis… - World journal of …, 2014 - ncbi.nlm.nih.gov
Serrated adenocarcinoma is a recently described subset of colorectal cancer (CRC), which
account for about 10% of all CRCs and follows an alternative pathway in which serrated …
account for about 10% of all CRCs and follows an alternative pathway in which serrated …
[HTML][HTML] Liquid biopsy for lung cancer: up-to-date and perspectives for screening programs
GMS Casagrande, MO Silva, RM Reis… - International Journal of …, 2023 - mdpi.com
Lung cancer is the deadliest cancer worldwide. Tissue biopsy is currently employed for the
diagnosis and molecular stratification of lung cancer. Liquid biopsy is a minimally invasive …
diagnosis and molecular stratification of lung cancer. Liquid biopsy is a minimally invasive …
PD-L1 expression by Tumor Proportion Score (TPS) and Combined Positive Score (CPS) are similar in non-small cell lung cancer (NSCLC)
…, ECA da Silva, VCC de Lima, RM Reis - Journal of Clinical …, 2021 - jcp.bmj.com
Background For non-small cell lung cancer (NSCLC) the most used method for analysing
programmed cell death ligand 1 (PD-L1) expression is the Tumor Proportion Score (TPS). …
programmed cell death ligand 1 (PD-L1) expression is the Tumor Proportion Score (TPS). …
[HTML][HTML] Relationship between Fusobacterium nucleatum, inflammatory mediators and microRNAs in colorectal carcinogenesis
…, GN Berardinelli, A Caetano, RM Reis… - World journal of …, 2018 - ncbi.nlm.nih.gov
AIM To examine the effect of Fusobacterium nucleatum (F. nucleatum) on the microenvironment
of colonic neoplasms and the expression of inflammatory mediators and microRNAs (…
of colonic neoplasms and the expression of inflammatory mediators and microRNAs (…
[HTML][HTML] Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation
…, AF Evangelista, V de Lima Vazquez, RM Reis… - Pharmacological …, 2016 - Elsevier
The BRAF V600E mutation confers constitutive kinase activity and accounts for >90% of
BRAF mutations in melanoma. This genetic alteration is a current therapeutic target; however, …
BRAF mutations in melanoma. This genetic alteration is a current therapeutic target; however, …
Screen-printed interdigitated electrodes modified with nanostructured carbon nano-onion films for detecting the cancer biomarker CA19-9
Nanostructured capacitive biosensors, combined with inexpensive fabrication technologies,
may provide simple, sensitive devices for detecting clinically relevant cancer biomarkers. …
may provide simple, sensitive devices for detecting clinically relevant cancer biomarkers. …